Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

200.22
Delayed Data
As of Sep 27
 +1.13 / +0.57%
Today’s Change
147.60
Today|||52-Week Range
231.32
-2.33%
Year-to-Date
Whitman's Third Avenue Buys 3 Pharma Stocks in 3rd Quarter
Sep 27 / GuruFocus News - Paid Partner Content
Shire's Immunodeficiency Treatment Cuvitru Gets FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Mairs and Power Buys Walt Disney, Exits Baxalta
Sep 27 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close199.09
Today’s open197.58
Day’s range196.90 - 200.74
Volume1,212,415
Average volume (3 months)1,995,742
Market cap$59.9B
Dividend yield0.40%
Data as of 09/27/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+10.33%
Earnings growth (next 5 years)+13.91%
Revenue growth (last year)+6.79%
P/E ratio32.5
Price/Sales6.33
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.65+1.56%
REGNRegeneron Pharmaceut...+17.33+4.29%
CELGCelgene+1.09+1.03%
AZNAstraZeneca+0.06+0.18%
Data as of 8:15am ET, 09/28/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)$3.25
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs